BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sousa LP, Pinho V, Teixeira MM. Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19? Br J Pharmacol 2020;177:3898-904. [PMID: 32557557 DOI: 10.1111/bph.15164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chiang N, de la Rosa X, Libreros S, Pan H, Dreyfuss JM, Serhan CN. Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation. Proc Natl Acad Sci U S A 2021;118:e2013374118. [PMID: 33649212 DOI: 10.1073/pnas.2013374118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Melo EM, Del Sarto J, Vago JP, Tavares LP, Rago F, Gonçalves APF, Machado MG, Aranda-Pardos I, Valiate BVS, Cassali GD, Pinho V, Sousa LP, A-Gonzalez N, Campagnole-Santos MJ, Bader M, Santos RAS, Machado AV, Ludwig S, Teixeira MM. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection. Pharmacol Res 2021;163:105292. [PMID: 33171305 DOI: 10.1016/j.phrs.2020.105292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Sandhaus S, Swick AG. Specialized proresolving mediators in infection and lung injury. Biofactors 2021;47:6-18. [PMID: 33249673 DOI: 10.1002/biof.1691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Barksdale C, Kipper FC, Tripathy S, Subbian S, Serhan CN, Panigrahy D. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev 2022. [PMID: 35190921 DOI: 10.1007/s10555-021-10017-z] [Reference Citation Analysis]
5 Jardou M, Lawson R. Supportive therapy during COVID-19: The proposed mechanism of short-chain fatty acids to prevent cytokine storm and multi-organ failure. Med Hypotheses 2021;154:110661. [PMID: 34385045 DOI: 10.1016/j.mehy.2021.110661] [Reference Citation Analysis]
6 Sousa LP, Pinho V, Teixeira MM. Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19? Br J Pharmacol 2020;177:3898-904. [PMID: 32557557 DOI: 10.1111/bph.15164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]